Review



primary antibodies for western blotting against cyt c  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc primary antibodies for western blotting against cyt c
    MAPKs, NAMPT, and SIRT1 changes according to the group. (A) C26-induced cancer cachexia was associated either ERK and JNK activation, then NR administration significantly inactivated these cachexia-associated MAPKs. (B) <t>NAMPT1</t> was significantly decreased in cancer cachexia group, suggesting incomplete conversion of NAD + in cancer cachexia, whereas NR administration maintained NAMPT1 expression. (C) SIRT1 was significantly increased in cancer cachexia group, but not in the NR-treated group, suggesting that NR administration did not affect SIRT1-mediated muscle atrophy.
    Primary Antibodies For Western Blotting Against Cyt C, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies for western blotting against cyt c/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies for western blotting against cyt c - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "Nicotinamide Riboside Vitamin B3 Mitigated C26 Adenocarcinoma–Induced Cancer Cachexia"

    Article Title: Nicotinamide Riboside Vitamin B3 Mitigated C26 Adenocarcinoma–Induced Cancer Cachexia

    Journal: Frontiers in Pharmacology

    doi: 10.3389/fphar.2021.665493

    MAPKs, NAMPT, and SIRT1 changes according to the group. (A) C26-induced cancer cachexia was associated either ERK and JNK activation, then NR administration significantly inactivated these cachexia-associated MAPKs. (B) NAMPT1 was significantly decreased in cancer cachexia group, suggesting incomplete conversion of NAD + in cancer cachexia, whereas NR administration maintained NAMPT1 expression. (C) SIRT1 was significantly increased in cancer cachexia group, but not in the NR-treated group, suggesting that NR administration did not affect SIRT1-mediated muscle atrophy.
    Figure Legend Snippet: MAPKs, NAMPT, and SIRT1 changes according to the group. (A) C26-induced cancer cachexia was associated either ERK and JNK activation, then NR administration significantly inactivated these cachexia-associated MAPKs. (B) NAMPT1 was significantly decreased in cancer cachexia group, suggesting incomplete conversion of NAD + in cancer cachexia, whereas NR administration maintained NAMPT1 expression. (C) SIRT1 was significantly increased in cancer cachexia group, but not in the NR-treated group, suggesting that NR administration did not affect SIRT1-mediated muscle atrophy.

    Techniques Used: Activation Assay, Expressing



    Similar Products

    primary antibodies for western blotting against cyt c  (Cell Signaling Technology Inc)
    90
    Cell Signaling Technology Inc primary antibodies for western blotting against cyt c
    MAPKs, NAMPT, and SIRT1 changes according to the group. (A) C26-induced cancer cachexia was associated either ERK and JNK activation, then NR administration significantly inactivated these cachexia-associated MAPKs. (B) <t>NAMPT1</t> was significantly decreased in cancer cachexia group, suggesting incomplete conversion of NAD + in cancer cachexia, whereas NR administration maintained NAMPT1 expression. (C) SIRT1 was significantly increased in cancer cachexia group, but not in the NR-treated group, suggesting that NR administration did not affect SIRT1-mediated muscle atrophy.
    Primary Antibodies For Western Blotting Against Cyt C, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies for western blotting against cyt c/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies for western blotting against cyt c - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    MAPKs, NAMPT, and SIRT1 changes according to the group. (A) C26-induced cancer cachexia was associated either ERK and JNK activation, then NR administration significantly inactivated these cachexia-associated MAPKs. (B) NAMPT1 was significantly decreased in cancer cachexia group, suggesting incomplete conversion of NAD + in cancer cachexia, whereas NR administration maintained NAMPT1 expression. (C) SIRT1 was significantly increased in cancer cachexia group, but not in the NR-treated group, suggesting that NR administration did not affect SIRT1-mediated muscle atrophy.

    Journal: Frontiers in Pharmacology

    Article Title: Nicotinamide Riboside Vitamin B3 Mitigated C26 Adenocarcinoma–Induced Cancer Cachexia

    doi: 10.3389/fphar.2021.665493

    Figure Lengend Snippet: MAPKs, NAMPT, and SIRT1 changes according to the group. (A) C26-induced cancer cachexia was associated either ERK and JNK activation, then NR administration significantly inactivated these cachexia-associated MAPKs. (B) NAMPT1 was significantly decreased in cancer cachexia group, suggesting incomplete conversion of NAD + in cancer cachexia, whereas NR administration maintained NAMPT1 expression. (C) SIRT1 was significantly increased in cancer cachexia group, but not in the NR-treated group, suggesting that NR administration did not affect SIRT1-mediated muscle atrophy.

    Article Snippet: Primary antibodies for Western blotting against NAMPT1, SIRT1, Pax7, ubiquitin, p-p38, ATGL (adipose triglyceride lipase), PARP-1, caspase-8, Bax, and Cyt c were from Cell Signaling Technology (Danvers, MA, United States).

    Techniques: Activation Assay, Expressing